Balance Sheet Bio-Works Technologies AB

Stocks

BIOWKS

SE0007387089

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET Other stock markets 2026-06-10			5-day change	1st Jan Change
3.770 ^SEK	+3.86%		-3.83%	+43.89%

Jun. 04	Bio-Works Technologies AB Approves Board Elections	CI
May. 13	Bio-Works swings to operating profit in the first quarter	FW

77edf976afb7ab83676.EgvqKpwihThRDrdU85JGubOAH9lnUj7BtNejFgDfGIw.WW-yRdRj11s2P_4SotQgjdjOU7VXFnD53pHQe3WRc_VqZoZs8GzSTQEj_g

Published financial data: BIO-WORKS TECHNOLOGIES AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	21.91M	41.32M	43.9M	25.46M	62.5M
Other Revenues, Total	34.45M	-	-	5.02M	-
Total Revenues	56.36M	41.32M	43.9M	30.49M	62.5M
Cost of Goods Sold, Total	3.35M	12.47M	17.08M	5.45M	14.7M
Gross Profit	53.01M	28.85M	26.82M	25.04M	47.8M
Selling General & Admin Expenses, Total	62.5M	74.95M	81.63M	60.2M	64.22M
Depreciation & Amortization - (IS)	707K	475K	611K	514K	512K
Other Operating Expenses	757K	569K	2.09M	118K	1.19M
Other Operating Expenses, Total	63.97M	75.99M	84.32M	60.83M	65.92M
Operating Income	-10.96M	-47.14M	-57.5M	-35.8M	-18.12M
Interest Expense, Total	-18K	-23K	-3K	-9K	-1K
Interest And Investment Income	72K	347K	882K	599K	550K
Net Interest Expenses	54K	324K	879K	590K	549K
Currency Exchange Gains (Loss)	1.53M	2.12M	1.89M	925K	407K
Other Non Operating Income (Expenses)	-	1K	-	-1K	-1K
EBT, Excl. Unusual Items	-9.37M	-44.7M	-54.73M	-34.28M	-17.16M
Restructuring Charges	-	-	-	-3M	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-9.37M	-44.7M	-54.73M	-37.28M	-17.16M
Income Tax Expense	3.57M	255K	2.09M	76K	-1.92M
Earnings From Continuing Operations	-12.94M	-44.95M	-56.82M	-37.36M	-15.25M
Net Income to Company	-12.94M	-44.95M	-56.82M	-37.36M	-15.25M
Net Income - (IS)	-12.94M	-44.95M	-56.82M	-37.36M	-15.25M
Net Income to Common Incl Extra Items	-12.94M	-44.95M	-56.82M	-37.36M	-15.25M
Net Income to Common Excl. Extra Items	-12.94M	-44.95M	-56.82M	-37.36M	-15.25M
Per Share Items
Net EPS - Basic	-0.41	-1.28	-1.57	-0.75	-0.18
Basic EPS - Continuing Operations	-0.41	-1.28	-1.57	-0.75	-0.18
Basic Weighted Average Shares Outstanding	31.21M	35.01M	36.11M	49.95M	82.76M
Net EPS - Diluted	-0.41	-1.28	-1.57	-0.75	-0.18
Diluted EPS - Continuing Operations	-0.41	-1.28	-1.57	-0.75	-0.18
Diluted Weighted Average Shares Outstanding	31.21M	35.01M	36.11M	49.95M	82.76M
Normalized Basic EPS	-0.19	-0.8	-0.95	-0.43	-0.13
Normalized Diluted EPS	-0.19	-0.8	-0.95	-0.43	-0.13
Supplemental Items
EBITDA	-10.47M	-46.67M	-56.89M	-35.28M	-17.61M
EBITA	-10.96M	-47.14M	-57.5M	-35.8M	-18.12M
EBIT	-10.96M	-47.14M	-57.5M	-35.8M	-18.12M
EBITDAR	-6.27M	-41.48M	-49.31M	-27.7M	-10.5M
Total Revenues (As Reported)	58.82M	43M	46.7M	32.94M	62.91M
Effective Tax Rate - (Ratio)	-38.12	-0.57	-3.81	-0.2	11.16
Normalized Net Income	-5.86M	-27.93M	-34.21M	-21.43M	-10.73M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	232K	-	-	-	-
Net Rental Expense, Total	4.2M	5.19M	7.59M	7.58M	7.1M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	103M	65.88M	39.38M	34.28M	34.93M
Total Cash And Short Term Investments	103M	65.88M	39.38M	34.28M	34.93M
Accounts Receivable, Total	4.66M	7.9M	7.15M	2.19M	12.69M
Other Receivables	2.18M	3.97M	2M	2.65M	4.24M
Total Receivables	6.84M	11.88M	9.16M	4.84M	16.94M
Inventory	7.85M	9.67M	9.07M	10.06M	15.64M
Prepaid Expenses	1.1M	1.33M	1.49M	1.34M	1.42M
Other Current Assets, Total	543K	426K	572K	158K	116K
Total Current Assets	119M	89.18M	59.66M	50.68M	69.05M
Gross Property Plant And Equipment	4.2M	5.32M	4.59M	4.43M	4.83M
Accumulated Depreciation	-2.41M	-2.89M	-2.1M	-2.61M	-3.12M
Net Property Plant And Equipment	1.78M	2.43M	2.49M	1.82M	1.71M
Goodwill	-	-	-	-	-
Other Intangibles, Total	-	-	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	-	-	-	1K	-
Total Assets	121M	91.61M	62.15M	52.5M	70.76M
Liabilities
Accounts Payable, Total	3.12M	6.8M	8.32M	2.52M	4.09M
Accrued Expenses, Total	4.82M	4.48M	5.37M	2.89M	6.25M
Current Income Taxes Payable	53K	-	2.24M	-	-
Other Current Liabilities	4.36M	12.64M	2.18M	2.5M	11.21M
Total Current Liabilities	12.35M	23.92M	18.12M	7.91M	21.55M
Other Non Current Liabilities	-	-	-	2K	1K
Total Liabilities	12.35M	23.92M	18.12M	7.91M	21.55M
Common Stock, Total	3.49M	3.52M	3.9M	7.8M	9.82M
Additional Paid In Capital	309M	313M	346M	380M	398M
Retained Earnings	-204M	-249M	-306M	-343M	-358M
Comprehensive Income and Other	1K	-	-	-	-1K
Total Common Equity	109M	67.69M	44.03M	44.58M	49.21M
Total Equity	109M	67.69M	44.03M	44.58M	49.21M
Total Liabilities And Equity	121M	91.61M	62.15M	52.5M	70.76M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	34.87M	35.16M	38.98M	77.96M	98.23M
ECS Total Common Shares Outstanding	34.87M	35.16M	38.98M	77.96M	98.23M
Book Value / Share	3.11	1.93	1.13	0.57	0.5
Tangible Book Value	109M	67.69M	44.03M	44.58M	49.21M
Tangible Book Value Per Share	3.11	1.93	1.13	0.57	0.5
Total Debt	0	0	0	0	0
Net Debt	-103M	-65.88M	-39.38M	-34.28M	-34.93M
Debt Equivalent Oper. Leases	33.58M	41.54M	60.69M	60.62M	56.84M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	2.74M	5.57M	5.55M	-	-
Inventories - Work In Process, Total	3.76M	2.93M	2.41M	-	-
Inventories - Finished Goods, Total	1.34M	1.18M	1.11M	-	-
Machinery, Total	4.2M	5.32M	4.59M	4.43M	4.83M
Full Time Employees	36.3	45.1	35.9	30	31

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-12.94M	-44.95M	-56.82M	-37.36M	-15.25M
Depreciation & Amortization - CF	489K	473K	611K	514K	512K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	489K	473K	611K	514K	512K
Amortization of Deferred Charges, Total - (CF)	268K	2K	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	0	-1K	2M	2K	0
Change In Accounts Receivable	-4.17M	-5.15M	2.42M	4.88M	-12.14M
Change In Inventories	-1.32M	-1.83M	605K	-996K	-5.58M
Change in Other Net Operating Assets	4.31M	11.57M	-7.8M	-10.21M	13.64M
Cash from Operations	-13.37M	-39.88M	-58.99M	-43.17M	-18.81M
Capital Expenditure	-942K	-1.12M	-860K	-8K	-404K
Sale of Property, Plant, and Equipment	-	-	-	166K	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-942K	-1.12M	-860K	158K	-404K
Issuance of Common Stock	86.67M	4.17M	33.65M	38.98M	20.26M
Other Financing Activities, Total	-2.71M	-132K	-389K	-1.23M	-181K
Cash from Financing	83.96M	4.04M	33.26M	37.75M	20.08M
Foreign Exchange Rate Adjustments	37K	97K	94K	155K	-213K
Miscellaneous Cash Flow Adjustments	-1K	-	-	-	-1K
Net Change in Cash	69.69M	-36.87M	-26.49M	-5.1M	653K
Supplemental Items
Cash Interest Paid	18K	23K	3K	9K	1K
Cash Income Tax Paid (Refund)	3.57M	255K	87K	76K	-1.92M
Levered Free Cash Flow	-8.23M	-25.53M	-38.97M	-28.2M	-15.29M
Unlevered Free Cash Flow	-8.22M	-25.52M	-38.97M	-28.19M	-15.29M
Change In Net Working Capital	1.18M	-4.6M	2.78M	6.33M	4.08M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-8.23	-27.73	-46.75	-39.03	-18.37
Return on Total Capital	-9.38	-33.44	-64.34	-50.49	-24.15
Return On Equity %	-17.73	-51.02	-101.72	-84.31	-32.51
Return on Common Equity	-17.73	-51.02	-101.72	-84.31	-32.51
Margin Analysis
Gross Profit Margin %	94.06	69.81	61.1	82.13	76.48
SG&A Margin	110.9	181.38	185.96	197.47	102.74
EBITDA Margin %	-18.58	-112.95	-129.61	-115.73	-28.17
EBITA Margin %	-19.44	-114.09	-131	-117.41	-28.99
EBIT Margin %	-19.44	-114.09	-131	-117.41	-28.99
Income From Continuing Operations Margin %	-22.96	-108.78	-129.44	-122.54	-24.39
Net Income Margin %	-22.96	-108.78	-129.44	-122.54	-24.39
Net Avail. For Common Margin %	-22.96	-108.78	-129.44	-122.54	-24.39
Normalized Net Income Margin	-10.39	-67.6	-77.93	-70.28	-17.16
Levered Free Cash Flow Margin	-14.6	-61.79	-88.78	-92.5	-24.47
Unlevered Free Cash Flow Margin	-14.58	-61.76	-88.77	-92.48	-24.47
Asset Turnover
Asset Turnover	0.68	0.39	0.57	0.53	1.01
Fixed Assets Turnover	36.19	19.6	17.84	14.16	35.44
Receivables Turnover (Average Receivables)	8.05	6.58	5.83	5.45	8.4
Inventory Turnover (Average Inventory)	0.47	1.42	1.82	0.57	1.14
Short Term Liquidity
Current Ratio	9.64	3.73	3.29	6.41	3.2
Quick Ratio	8.87	3.25	2.68	4.94	2.41
Operating Cash Flow to Current Liabilities	-1.08	-1.67	-3.26	-5.46	-0.87
Days Sales Outstanding (Average Receivables)	45.34	55.48	62.58	67.13	43.46
Days Outstanding Inventory (Average Inventory)	782.9	256.33	200.3	642.53	319.12
Average Days Payable Outstanding	205.85	126.58	167.55	308.05	59.53
Cash Conversion Cycle (Average Days)	622.38	185.23	95.33	401.61	303.05
Long Term Solvency
Total Liabilities / Total Assets	10.22	26.11	29.15	15.07	30.46
EBIT / Interest Expense	-608.78	-2.05K	-19.17K	-3.98K	-18.12K
EBITDA / Interest Expense	-581.61	-2.03K	-18.96K	-3.92K	-17.61K
(EBITDA - Capex) / Interest Expense	-633.94	-2.08K	-19.25K	-3.92K	-18.01K
Net Debt / EBITDA	9.81	1.41	0.69	0.97	1.98
Net Debt / (EBITDA - Capex)	9	1.38	0.68	0.97	1.94
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	679.08	-26.68	6.23	-30.55	105.02
Gross Profit, 1 Yr. Growth %	1.16K	-45.58	-7.02	-6.65	90.92
EBITDA, 1 Yr. Growth %	-76.99	345.83	21.9	-37.99	-54.01
EBITA, 1 Yr. Growth %	-76	330.22	21.98	-37.75	-53.3
EBIT, 1 Yr. Growth %	-76	330.22	21.98	-37.75	-53.3
Earnings From Cont. Operations, 1 Yr. Growth %	-71.25	247.32	26.41	-34.26	-59.19
Net Income, 1 Yr. Growth %	-71.25	247.32	26.41	-34.26	-59.19
Normalized Net Income, 1 Yr. Growth %	-79.52	377	22.46	-37.37	-53.96
Diluted EPS Before Extra, 1 Yr. Growth %	-71.98	209.62	22.53	-52.47	-75.44
Accounts Receivable, 1 Yr. Growth %	495.15	69.57	-9.5	-69.38	479.63
Inventory, 1 Yr. Growth %	20.28	23.26	-6.24	10.98	55.43
Net Property, Plant and Equip., 1 Yr. Growth %	34.03	36.38	2.3	-27	-5.89
Total Assets, 1 Yr. Growth %	165.63	-24.2	-32.16	-15.53	34.78
Tangible Book Value, 1 Yr. Growth %	189.97	-37.62	-34.95	1.25	10.37
Common Equity, 1 Yr. Growth %	189.7	-37.62	-34.95	1.25	10.37
Cash From Operations, 1 Yr. Growth %	-69.17	198.3	47.92	-26.82	-56.42
Capital Expenditures, 1 Yr. Growth %	188.96	19.32	-23.49	-99.07	4.95K
Levered Free Cash Flow, 1 Yr. Growth %	-69.76	210.34	52.63	-27.64	-49.15
Unlevered Free Cash Flow, 1 Yr. Growth %	-69.8	210.59	52.71	-27.65	-49.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	218.04	139	-11.75	-14.1	19.33
Gross Profit, 2 Yr. CAGR %	214.22	161.58	-28.87	-6.84	33.5
EBITDA, 2 Yr. CAGR %	-49.92	1.28	133.13	-13.05	-44.37
EBITA, 2 Yr. CAGR %	-49	1.62	129.08	-12.86	-43.87
EBIT, 2 Yr. CAGR %	-49	1.62	129.08	-12.86	-43.87
Earnings From Cont. Operations, 2 Yr. CAGR %	-44.56	-0.08	109.53	-8.84	-48.2
Net Income, 2 Yr. CAGR %	-44.56	-0.08	109.53	-8.84	-48.2
Normalized Net Income, 2 Yr. CAGR %	-52.83	-1.17	141.69	-12.42	-44
Diluted EPS Before Extra, 2 Yr. CAGR %	-45.41	-6.86	94.78	-23.68	-65.78
Accounts Receivable, 2 Yr. CAGR %	112.39	217.68	23.88	-47.36	33.23
Inventory, 2 Yr. CAGR %	6.16	21.76	7.5	2.01	31.34
Net Property, Plant and Equip., 2 Yr. CAGR %	24.17	35.2	18.12	-13.58	-17.11
Total Assets, 2 Yr. CAGR %	17.18	41.9	-28.29	-24.3	6.7
Tangible Book Value, 2 Yr. CAGR %	14.99	34.5	-36.3	-18.84	5.71
Common Equity, 2 Yr. CAGR %	14.94	34.43	-36.3	-18.84	5.71
Cash From Operations, 2 Yr. CAGR %	-42.22	-4.1	110.06	4.04	-43.53
Capital Expenditures, 2 Yr. CAGR %	106.93	85.68	-4.45	-91.56	-31.46
Levered Free Cash Flow, 2 Yr. CAGR %	-43.16	-3.13	117.64	5.09	-37.36
Unlevered Free Cash Flow, 2 Yr. CAGR %	-43.19	-3.15	117.78	5.11	-37.36
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	104.78	95.01	82.4	-18.52	14.79
Gross Profit, 3 Yr. CAGR %	105.17	75.15	85.29	-22.12	18.33
EBITDA, 3 Yr. CAGR %	-30.96	3.78	7.73	49.93	-27.74
EBITA, 3 Yr. CAGR %	-30.17	3.82	8	48.38	-27.3
EBIT, 3 Yr. CAGR %	-31.1	3.82	8	48.38	-27.3
Earnings From Cont. Operations, 3 Yr. CAGR %	-30.14	2.2	8.07	42.38	-30.26
Net Income, 3 Yr. CAGR %	-30.14	2.2	8.07	42.38	-30.26
Normalized Net Income, 3 Yr. CAGR %	-34.48	2	6.15	54.09	-27.32
Diluted EPS Before Extra, 3 Yr. CAGR %	-40.51	-2.64	2.06	21.72	-47.65
Accounts Receivable, 3 Yr. CAGR %	23.45	97.04	109.03	-22.25	17.12
Inventory, 3 Yr. CAGR %	9.39	11.58	11.6	8.65	17.38
Net Property, Plant and Equip., 3 Yr. CAGR %	10.65	28.12	23.2	0.61	-11.09
Total Assets, 3 Yr. CAGR %	21.49	1.34	10.96	-24.27	-8.25
Tangible Book Value, 3 Yr. CAGR %	21.46	-6.21	5.57	-25.66	-10.09
Common Equity, 3 Yr. CAGR %	20.74	-6.24	5.54	-25.66	-10.09
Cash From Operations, 3 Yr. CAGR %	-27.23	-0.13	10.81	47.8	-22.16
Capital Expenditures, 3 Yr. CAGR %	6.45	72.23	38.17	-79.6	-28.9
Levered Free Cash Flow, 3 Yr. CAGR %	-29.11	0.09	12.72	50.77	-15.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	-29.14	0.08	12.73	50.83	-15.69
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	54.11	45.13	46.24	40.48	53.92
Gross Profit, 5 Yr. CAGR %	51.87	40.55	34.3	36.06	62.52
EBITDA, 5 Yr. CAGR %	-7.48	16.28	12.33	-3.31	-17.3
EBITA, 5 Yr. CAGR %	-7.01	16.2	12.31	-3.21	-16.88
EBIT, 5 Yr. CAGR %	-8.51	14.86	11.41	-3.21	-16.88
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.48	13.7	8.4	-2.37	-19.47
Net Income, 5 Yr. CAGR %	-5.48	13.7	8.4	-2.37	-19.47
Normalized Net Income, 5 Yr. CAGR %	-11.39	13.57	10.44	-4.03	-17.81
Diluted EPS Before Extra, 5 Yr. CAGR %	-26.92	1.03	-4.4	-11.68	-34.08
Accounts Receivable, 5 Yr. CAGR %	81.13	59.4	23.62	16.22	74.57
Inventory, 5 Yr. CAGR %	16.02	20.7	8.63	7.65	19.11
Net Property, Plant and Equip., 5 Yr. CAGR %	22.41	21.66	13.58	9.45	5.14
Total Assets, 5 Yr. CAGR %	33.9	-2.75	-1.61	-9.82	9.23
Tangible Book Value, 5 Yr. CAGR %	40.49	-6.92	-6.17	-11.49	5.63
Common Equity, 5 Yr. CAGR %	35.63	-7.38	-6.51	-11.5	5.61
Cash From Operations, 5 Yr. CAGR %	-1.55	13.44	11.2	1.52	-15.38
Capital Expenditures, 5 Yr. CAGR %	96.69	15.12	1.95	-48.46	4.38
Levered Free Cash Flow, 5 Yr. CAGR %	-5.49	12.22	11.03	2.06	-10.88
Unlevered Free Cash Flow, 5 Yr. CAGR %	-5.34	12.27	11.03	2.06	-10.88